Abstract
Combination chemotherapy with procarbazine, CCNU and vincristine (PCV) may be effective in patients with recurrent glioma. Response monitoring is mandatory, but radiological response evaluation is often difficult. We evaluated Thallium-201 (201Tl) SPECT as a response parameter in ten patients treated with intensive PCV chemotherapy for recurrent glioma. 201Tl-SPECT studies showed early changes (decreasing volume and intensity) in nine patients and these changes were more pronounced than radiological findings. 201Tl-SPECT results after completion of chemotherapy seemed to correlate with clininal findings during follow up. We conclude that 201Tl-SPECT may contribute to the assessment of response in patients treated with PCV chemotherapy for recurrent glioma.
Similar content being viewed by others
References
Levin VA, Edwards MS, Wright DC, Seager ML, Pischer Schimberg T, Townsend JJ, Wilson CB: Modified procarbazine, CCNU and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep 64: 237–241, 1980
Cairncross JG, Macdonald DR: Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23: 360–364, 1988
Macdonald DR, Cascino TL, Schold Jr SC, Cairncross JG: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277–1280, 1990
Slizofsky WJ, Krishna L, Katsctos CD, Black P, Miyamoto C, Brown SJ, Vender J, Chevres A, Khan AS, McEvan J, Dadparvar D: Thallium imaging for brain tumors with results measured by a semiquantitative index and correlated with histopathology. Cancer 74: 3190–3197, 1994
Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, Shidara N: Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumor. Ann of Nucl Med 4: 257–263, 1993
Mountz JM, Raymund PA, Mckeever PE, Modell JG, Hood TW, Barthel LK, Stafford-Schuck KA: Specific localization of Thallium 201 in human high-grade astrocytoma by microautoradiography. Cancer Res 49: 4053–4056, 1989
Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connoly BT, Atkins HL: Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 28: 47–52, 1987
Caircross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Steward D, Schold Jr C, Wainman N, Eisenhauer E: Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12: 2013–2021, 1994
Fine HA, Dear KB, Loeffler JS: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585–2597, 1993
Mason WP, DeAngelis LM: Procarbazine, CCNU, Vincristine (PCV) chemotherapy (CT) for benign oligodendrogliomas. Neurology 44: 262–263, 1994
Levin VA, Silver P, Hannigan J: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18: 321–324, 1990
Doom GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, Newton TH: Brain radiation necrosis: MR imaging. Radiology 158: 149–155, 1986
Brada M, Sharpe G: Chemotherapy of high-grade gliomas. Beginning of a new era or the end of the old? Eur J Cancer 32A: 2193–2194, 1997
Black KL, Emerick T, Hoh CK, Hawkins RA, Mazziota J, Becker DP: Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. Neurol Res 16: 93–96, 1994
Lorberboym M, Mandell LR, Mosesson RE, Germano I, Lou W, DaCosta M, Linzer DG, Machac J: The role of Thallium-201 uptake and retention in intracranial tumors after radiotherapy. J Nucl Med 38: 223–226, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roesdi, M., Postma, T., Hoekstra, O. et al. Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma. J Neurooncol 40, 251–255 (1998). https://doi.org/10.1023/A:1006090807678
Issue Date:
DOI: https://doi.org/10.1023/A:1006090807678